患者控制注射器市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00015234
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Patient Controlled Injectors Market Growth Report | 2021 to 2031

Buy Now

2021 年患者控制注射器市场规模为 37.1 亿美元,预计到 2031 年将从 2023 年的 XX 亿美元增至 123.3 亿美元。预计 2023-2031 年市场复合年增长率为 12.9%。可穿戴注射器(例如集成蓝牙的可穿戴注射器)的技术进步使向患者传输信号(例如注射提醒)成为可能,并为患者提供治疗数据访问权限,这些可能仍是患者控制注射器市场的关键趋势。

 

患者控制注射器市场分析

糖尿病、类风湿性关节炎和自身免疫性疾病等慢性病的患病率不断上升,这导致患者自控注射器的需求增加。这些设备为需要频繁注射疾病控制药物的患者提供了舒适性和易用性。患者自控注射器市场使患者能够在家中自行给药,从而减少了频繁就诊的需要并增加了患者的便利性。

 

患者控制注射器市场概况

疫情期间,患者自控注射器的需求有所增加。患者人数增加、医疗资源短缺以及注射器普及率提高等因素在一定程度上对市场产生了积极影响。然而,为防止病毒感染而实施的社交距离政策和企业关闭扰乱了供应链流程,对市场增长产生了负面影响。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

患者控制注射器市场:

患者控制注射器市场
  • Patient Controlled Injectors Market
    复合年增长率(2023 - 2031)
    12.9%
  • 2021 年市场规模
    37.1 亿美元
  • 2031年市场规模
    123.3亿美元

市场动态

增长动力
  • 慢性病患病率上升
  • 患者依从性提高
未来的趋势
  • 可穿戴注射器的技术进步
机会
  • 采用自行用药

关键人物;主力;重要一员

  • 格雷斯海姆股份公司
  • 强生服务公司
  • 伊普索梅德公司
  • 威斯特伯恩医疗有限公司
  • 启用注入
  • scPharmaceuticals Inc.
  • 联合治疗公司
  • 屋宇署
  • 西方制药服务公司
  • 欧文·芒福德制药服务公司

区域概况

Patient Controlled Injectors Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Patient Controlled Injectors Market产品
  • 电子可穿戴注射器
  • 机械可穿戴注射器
  • 输液泵
Patient Controlled Injectors Market应用
  • 癌症治疗
  • 自身免疫治疗
  • 血液疾病治疗
  • 其他的
Patient Controlled Injectors Market分销渠道
  • 医院药房
  • 零售药店
  • 邮购药店
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

患者控制注射器市场驱动因素和机遇

 

患者依从性提高有利于市场增长

预计患者控制注射器在市场上将同时崛起,因为注射过程更加轻松、安全和舒适,很可能在患者中大受欢迎。除此之外,患者控制注射器的控制释放有助于患者自行给药并决定剂量率。

除此之外,确保医护人员的安全也至关重要。根据美国国立卫生研究院 (NIH) 于 2023 年发表的一篇文章,在发展中国家,医护人员中 40-65% 的乙肝感染可归因于经皮职业暴露。许多制造商现在专注于开发患者控制注射器以满足尚未满足的需求,这反过来又刺激了市场的增长。

 

采用自行用药

患者使用自行用药来控制血压、血糖和其他慢性疾病。自行用药是指消费者使用药品来治疗自我诊断的疾病或症状,以及间歇性或连续使用医生推荐的药物来治疗慢性或复发性疾病或症状。慢性疾病需要重复用药,因此这些适应症代表着巨大的药物量和收入机会。根据 2023 年 6 月发表在《柳叶刀》上的一项研究,到 2050 年,全球糖尿病患者数量预计将达到 13 亿。糖尿病自我管理是根据自我测量的毛细血管血糖读数确定和给予胰岛素剂量的技术。自行用药治疗糖尿病是根据自我测量的毛细血管血糖读数给予胰岛素剂量。

 

患者控制注射器市场报告细分分析

有助于得出患者控制注射器市场分析的关键部分是产品、应用和分销渠道。

  • 根据产品,患者控制注射器市场分为电子可穿戴注射器、机械可穿戴注射器和输液泵。电子可穿戴注射器部分在 2023 年占据了更大的市场份额。
  • 根据原因,市场分为癌症治疗、自身免疫治疗、血液病治疗等。2023 年,癌症治疗领域占据了最大的市场份额。
  • 就类别而言,市场分为医院药房、零售药房和邮购药房。医院药房部分在 2023 年占据了市场主导地位。

 

患者控制注射器市场份额(按地区)分析

患者控制注射器市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美一直主导着患者控制注射器市场。北美市场的增长特点是癌症、自身免疫性疾病、心血管疾病等慢性疾病的患病率不断上升,以及该地区创新产品的开发和主要市场参与者的存在。此外,治疗疾病的技术进步很可能成为该地区患者控制注射器市场的主要增长刺激因素。  

 

患者控制注射器市场报告范围

报告属性细节
2021 年市场规模37.1亿美元
2031 年市场规模123.3亿美元
全球复合年增长率(2023 - 2031)12.9%
历史数据2021-2022
预测期2023-2031
涵盖的领域按产品
  • 电子可穿戴注射器
  • 机械可穿戴注射器
  • 输液泵
按应用
  • 癌症治疗
  • 自身免疫治疗
  • 血液疾病治疗
  • 其他的
按分销渠道
  • 医院药房
  • 零售药店
  • 邮购药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 格雷斯海姆股份公司
  • 强生服务公司
  • 伊普索梅德公司
  • 威斯特伯恩医疗有限公司
  • 启用注入
  • scPharmaceuticals Inc.
  • 联合治疗公司
  • 屋宇署
  • 西方制药服务公司
  • 欧文·芒福德制药服务公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

患者控制注射器市场新闻和最新发展

通过收集初步和二次研究后的定性和定量数据来评估患者控制注射器市场,其中包括重要的公司出版物、协会数据和数据库。以下是患者控制注射器市场的发展列表:

  • Ypsomed (SIX: YPSN) 开发了一种新型自动注射器平台,用于注射容量从 1.5 毫升到 5.5 毫升的液体药物。YpsoMate 5.5 是不断壮大的 YpsoMate 设备系列的最新成员,基于 YpsoMate 2.25 Pro 的成熟技术。YpsoMate 5.5 可自行注射大剂量药物,用于治疗癌症、罕见病和自身免疫性疾病。(来源:Ypsomed AG,新闻稿,2022 年)
  • Gerresheimer 从 Midas Pharma 收购了新一代基于药筒的自动注射器的知识产权。这是战略合作伙伴关系的开始。该联合项目包括新一代自动注射器的开发和营销。(来源:Gerresheimer AG,新闻稿,2021 年)

 

患者控制注射器市场报告覆盖范围和交付成果

“患者控制注射器市场规模和预测(2021-2031)”报告对市场进行了详细的分析,涵盖以下领域:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..